| Date | Form | Description | Docs | XBRL | Pages |
| 01/18/05 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
51 | |
| 01/18/05 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
59 | |
| 01/18/05 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT |
|
3 | |
| 12/22/03 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
51 | |
| 02/13/03 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
49 | |
| 01/29/03 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT |
|
3 | |
| 01/29/02 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
48 | |
| 02/01/01 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
35 | |
| 01/29/01 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
35 | |
| 01/28/00 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
60 |
Latest News & Events
Anixa Biosciences to Present at the B. Riley Oncology Investor Conference
Read More...Anixa Biosciences to Present at the H.C. Wainwright BioConnect 2021 Conference
Read More...Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical Trial of Breast Cancer Vaccine
Read More...